J. Kwong

发表

Methods used for immunization coverage assessment in Canada, a Canadian Immunization Research Network (CIRN) study

K. Tu, Sarah E. Wilson, S. Deeks, 2017, Human vaccines & immunotherapeutics.

Improving estimates of pertussis burden in Ontario, Canada 2010–2017 by combining validation and capture-recapture methodologies

F. Rudzicz, N. Crowcroft, K. Brown, 2022, medRxiv.

Association between long-term exposure to ambient air pollution and COVID-19 severity: a prospective cohort study

A. van Donkelaar, J. Kaufman, É. Lavigne, 2022, Canadian Medical Association Journal.

Impact of availability of direct-acting antivirals for hepatitis C on Canadian hospitalization rates, 2012-2016.

D. Schanzer, N. Janjua, M. Gale-Rowe, 2018, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

P. Austin, K. Wilson, J. Kwong, 2022, Nature Communications.

Effectiveness of a Fourth Dose of COVID-19 Vaccine among Long-Term Care Residents in Ontario, Canada

S. Buchan, J. Kwong, S. Wilson, 2022, medRxiv.

Vaccine effectiveness of BNT162b2 against Omicron and Delta outcomes in adolescents

S. Buchan, J. Kwong, S. Wilson, 2022, medRxiv.

Natural Language Processing for Clinical Laboratory Data Repository Systems: Implementation and Evaluation for Respiratory Viruses

B. Chen, S. Mubareka, J. Kwong, 2022, medRxiv.

Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada

A. Garg, A. Levin, E. McArthur, 2022, Journal of the American Society of Nephrology : JASN.

Effectiveness of COVID-19 vaccines against Omicron or Delta infection

M. Sundaram, K. Brown, S. Buchan, 2022, medRxiv.

Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA Vaccine among Long-Term Care Residents in Ontario, Canada

S. Buchan, J. Kwong, S. Wilson, 2022, medRxiv.

Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged >=50 years in Ontario, Canada

K. Brown, S. Buchan, J. Kwong, 2023, medRxiv.

Canadian vaccine research networks: Vaccine safety resources for Canada.

J. Langley, S. Deeks, N. Crowcroft, 2015, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Effect of sustained viral clearance on liver-related mortality among individuals living with hepatitis C by treatment era: a population-based retrospective cohort study

N. Janjua, J. Kwong, A. Erman, 2022, medRxiv.

Area-level social and structural inequalities determine mortality related to COVID-19 diagnosis in Ontario, Canada: a population-based explanatory modeling study of 11.8 million people

P. Austin, S. Mishra, B. Sander, 2022, medRxiv.

Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults

K. Brown, S. Buchan, J. Kwong, 2023, medRxiv.